Pharmacologic target | Compounds | Effect on activity or excitability |
---|---|---|
Ligand-gated ion channels | Â | Â |
   5-HT3 receptor | 5-HT, phenylbiguanide | ↑ |
   P2X receptor | ATP | ↑ |
   Nicotinic receptor | Nicotine, acetylcholine | ↑ |
   VR1 | Capsaicin, resiniferatoxin, various acids | ↑ |
GPCRs | Â | Â |
   Histamine H1 receptor | Histamine | ↑ |
   Bradykinin B2 receptor | Bradykinin | ↑ |
   Adenosine A1 receptor | Adenosine | ↑ |
   Prostanoid receptors | PGE2, PGD2, PGF2α, TXA2, PGI2 | ↑ |
   Opioid μ receptors | Endomorphins, DAMGO | ↓ |
   Cys-LT1 receptors | Cysteinyl leukotrienes | ↑ |
   NK1, NK2 receptors | Substance P, neurokinin A | ↑ |
Voltage-gated ion channels | Â | Â |
   Sodium channels | Tetrodotoxin | ↓ |
 | Lidocaine | ↓ |
 | Veratridine | ↑ |
 | Amiloride | ↓ |
   Potassium channels | 4-Aminopyridine | ↑ |
 | α-Dendrotoxin | ↑ |
 | NS1619 | ↓ |
 | Iberiotoxin | ↑ |
Unknown targets | Â | Â |
 | Ozone | ↑ |
 | Sulfur dioxide | ↑ |
 | Acetone | ↑ |
 | Water | ↑ |
 | Low-chloride solutions | ↑ |
 | Furosemide | ↓↑ |